Gefitinib-based PROTAC 3 is targeting on EGFR, consisting of Gefitinib as the warhead linked to VHL-recruiting ligand.
Product Details
| Formula: | C47H57ClFN7O8S |
| |
| MW: | 934.5 |
| |
| CAS: | 2230821-27-7 |
| |
| Purity: | ≥99% |
| |
| Appearance: | White solid. |
| |
| Solubility: | Soluble in DMSO (75 mg/mL). Insoluble in water. |
| |
| Shipping: | Blue Ice |
| |
| Long Term Storage: | -20°C |
| |
| Regulatory Status: | RUO - Research Use Only |
| |
Please mouse over
General Literature References
The Advantages of Targeted Protein Degradation Over Inhibition: An RTK Case Study: G.M. Burslem, et al.; Cell Chem. Biol.
25, 67 (2018),
Abstract;
Full Text
